Medicine & Life Sciences
pevonedistat
100%
Thionucleosides
70%
Adenosine A3 Receptor Antagonists
68%
Selenium
49%
Adenosine A3 Receptors
45%
Nucleosides
44%
Structure-Activity Relationship
43%
human ADORA3 protein
38%
Adenosine
38%
Purinergic P1 Receptors
36%
2-(2-chloro-6-(3-iodobenzylamino)-9H-purine-9-yl)tetrahydrothiophene-3,4-diol
32%
Peroxisome Proliferator-Activated Receptors
31%
4'-thioadenosine
31%
Enzyme Inhibitors
30%
Ribose
29%
Pyrimidines
28%
Ligands
27%
Adenosine A3 Receptor Agonists
25%
N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine
24%
Cullin Proteins
24%
Mannose
23%
Apoptosis
22%
Adenine
20%
Neoplasms
20%
Activating Transcription Factor 4
20%
Antiviral Agents
19%
Cytarabine
17%
LJ-2698
17%
Cell Death
16%
Purinergic P1 Receptor Agonists
16%
Lung Neoplasms
16%
Sugars
16%
Antineoplastic Agents
15%
Adipogenesis
15%
Adiponectin
15%
Chemotactic Factors
14%
Correlation of Data
14%
Prostatic Neoplasms
14%
erythronic acid
14%
Human Herpesvirus 1
14%
Ubiquitin-Protein Ligases
14%
Apolipoproteins E
14%
X-Rays
13%
Triazoles
13%
Microglia
13%
Hypercholesterolemia
13%
Hominidae
13%
Molecular Dynamics Simulation
12%
Ganciclovir
12%
Prodrugs
12%
Chemical Compounds
Adenosine
70%
Nucleoside
70%
Antagonist
60%
Adenosine A3 Receptor Antagonist
44%
Receptor Binding Affinity
36%
Selenium Atom
35%
Antiviral Agent
34%
D-Ribose
33%
Structure-Activity Relationship
30%
Nucleobase
28%
Adiponectin
27%
Adenosine A3 Receptor Agonist
27%
Anti HCMV
23%
Antineoplastic Agent
22%
Cell Death
19%
Pummerer Reaction
19%
Adenine
19%
Enzyme Inhibitor
18%
Kd
18%
Agonist
18%
D-Mannose
18%
Pyrimidine
17%
Prodrug
16%
Stille Reaction
16%
Nucleophilic Aromatic Substitution
16%
Anti HIV
16%
Receptor Modulator
15%
Antifibrotic
15%
Peroxisome Proliferator Activated Receptor Antagonist
13%
Interstitial
13%
Pyrimidin-5-Amine
13%
Condensation Reaction
12%
Phosphoramidate
12%
DNA Polymerase Inhibitor
12%
Cannabinoid Receptor Agonist
11%
Silencing RNA
11%
Protein
11%
Peroxisome Proliferator
10%
Diselenide
10%
Anti Herpes
10%
Cytosine
10%
Ganciclovir
10%
2,6-diaminopurines
10%
Post-Translational Protein Modification
10%
Sharpless Asymmetric Epoxidation
9%
Anti Hepatitis
9%
Anti-HIV Agent
9%
Wittig Olefination
9%
Bioactivity
9%
Cell Viability
9%